Henry Woo,MBBS,DMedSc FRACS(Urol) FUSANZ FACS

OPEN IN VIEWER

Professor Henry Woo

We are delighted to celebrate our phenomenal reviewers who will be recognized every month. The quality of the journal is entirely dependent on the authors for choosing our journal for their manuscripts and reviewers for ensuring that the submissions are improved. The spotlighted reviewers were selected based on the number, quality and turnaround time of manuscripts reviewed during the last two years. We are also grateful to our Editorial Board for sharing the burden of the reviews.

Professor Henry Woo is a urological surgeon from Sydney, Australia. He is Head of Department of Urology at Blacktown and Mount Druitt Hospitals as well as the Director of Uro-Oncology at the Chris O’Brien Lifehouse Comprehensive Cancer Center. He is an honorary professor at the Australian National University and a Conjoint Professor at the Western Sydney University. Prior academic positions included professor surgery at the University of Sydney and professor of urology at the Australian National University.

He is a Fellowship Elected Councillor of the Royal Australasian College of Surgeons (RACS), where he currently holds the portfolio of Chair of Professional Standards. For three years prior to this, he held the portfolio position as Chair of Research and Academic Surgery. He is a board director of the Australian and New Zealand Uro-genital and Prostate Cancer Trials Group (ANZUP) and the Australasian Urological Foundation (AUF). He has previously served on the Board of Directors for the Urological Society of Australia and New Zealand (USANZ).

His principal research interests include minimally invasive surgical treatment options for benign prostatic obstruction, prostate cancer, clinical trials in urology, and professionalism in surgery. He has published over 200 manuscripts and is an internationally recognized academic contributor to the field. He currently serves as an associate editor to the SIU Journal and serves on the editorial boards of multiple international journals, including Prostate Cancer and Prostatic Diseases, World Journal of Urology, World Journal of Men’s Health, Prostate International, European Urology Open Science, and Journal of Urology Open Plus. He has previously served on the editorial boards of the BJUI and European Urology.

He has vast experience in organizing scientific congresses. He has organized numerous national symposiums and workshops and, in particular, has previously been the convenor of the USANZ ASM and the ANZUP ASM. He is currently the appointed convenor of the RACS Annual Scientific Congress to be held in 2025. More recently, he led the successful bid to host WCET in Sydney in 2027.